Showing results (21-30 of 147) with videos related to
Sort By:
Pageof 15
Current Gene Therapy|November 6, 2007
Immune responses to AAV in clinical trialsFederico Mingozzi, Katherine A HighNature Reviews. Genetics|April 19, 2011
Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challengesFederico Mingozzi, Katherine A HighMolecular Therapy : the Journal of the American Society of Gene Therapy|January 25, 2007
Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytesHua Li, Samuel L Murphy, Wynetta Giles-Davis, et al.Current Opinion in Pharmacology|July 13, 2010
Viral vector-mediated RNA interferenceLinda B Couto, Katherine A HighBlood Advances|April 9, 2024
Hemophilia B and gene therapy: a new chapter with etranacogene dezaparvovecXavier M Anguela, Katherine A HighCold Spring Harbor Perspectives in Medicine|September 12, 2022
Trial by "Firsts": Clinical Trial Design and Regulatory Considerations in the Development and Approval of the First AAV Gene Therapy Product in the United StatesKathleen Z Reape, Katherine A HighAnnual Review of Medicine|November 28, 2018
Entering the Modern Era of Gene TherapyXavier M Anguela, Katherine A HighHuman Molecular Genetics|November 29, 2015
Adeno-associated viral vectors for the treatment of hemophiliaKatherine A High, Xavier M AnguelaMolecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2008
Undetectable transcription of cap in a clinical AAV vector: implications for preformed capsid in immune responsesBernd Hauck, Samuel L Murphy, Peter H Smith, et al.Human Gene Therapy|January 3, 2017
Impact of AAV Capsid-Specific T-Cell Responses on Design and Outcome of Clinical Gene Transfer Trials with Recombinant Adeno-Associated Viral Vectors: An Evolving ControversyHildegund C J Ertl, Katherine A HighPageof 15